MalarVx, Inc.
Home
ABOUT
The challenge
The Disease – Malaria
The Team
R&D
Vaccine Development
In vitro mosquito-stages
Pipeline
Publications
News
Contact
Citations
MEDIA
MalarVx licenses HDT Bio’s repRNA/LION™ Technology for Novel Malaria Vaccine
By
Marion Avril
|
4
Jun, 25
|
Exciting Milestone
By
Marion Avril
|
14
Jan, 25
|
We've captured, for the first time, live footage of Plasmodium…
ASTMH 2024,New Orleans, LA, USA
By
Marion Avril
|
14
Jan, 25
|
In New Orleans, Louisiana, US, in November 2024, at the…
Podcast TWiP 236
By
Marion Avril
|
6
Jun, 24
|
Marion Avril of MalarVx, Inc. joins TWiP to discuss an…
ASTMH 2023, Chicago, IL, USA
By
Marion Avril
|
20
Oct, 23
|
In 2023, Dr. Marion Avril, the Principal Scientist and Program…
ASTMH 2022- Seattle, WA USA
By
Marion Avril
|
1
Nov, 22
|
MalarVx Inc. participated in the 2022 American Society of Tropical…
ASTMH 2021 – virtual
By
Marion Avril
|
17
Nov, 21
|
MalarVx Inc. participated remotely at the virtual 2021 American Society…
